Poland· PL-100147065
Procoralan
A ivabradine product containing ivabradinum, registered in Poland by Les Laboratoires Servier. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Ivabradine is registered in 19 of 19 countries.
Countries holding a registration under ATC C01EB17 (ivabradine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Ivabradine · ATC C01EB17
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ivabradine costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.59 in France to $1.75 in Switzerland — a ×2.9 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ivabradine · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.75
- ES Spain$1.17
- IT Italy$0.81
- FR France$0.59
The record
At a glance
URPL (Poland)- Active substance
- Ivabradinum
- Manufacturer
- Les Laboratoires Servier
- Country
- Poland (PL)
- ATC code
- C01EB17
- ATC class
- Ivabradine
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990340453
- gtin05909990340460
- gtin05909990340477
- gtin05909990340484
- gtin05909990609222
- gtin05901878600406
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for ivabradine.
Graded by severity as the source publishes them — 128 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ivabradine · interactions on record
203 records
- 128 severe
- 61 moderate
Most severe, free to view
- ClotrimazoleA01AB18severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
14 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01EB17
Ivabradine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/77d7132e-5418-4509-82b2-8c96b7c9eb0e GET /v1/drugs/77d7132e-5418-4509-82b2-8c96b7c9eb0e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "7,5 mg",
"packaging": "05909990340453 ¦ Rp ¦ EU/1/05/316/008 ¦ 29428\n14 tabl.\n05909990340460 ¦ Rp ¦ EU/1/05/316/009 ¦ 29429\n28 tabl.\n05909990340477 ¦ Rp ¦ EU/1/05/316/010 ¦ 29430\n56 tabl.\n05909990340484 ¦ Rp ¦ EU/1/05/316/013 ¦ 29431\n100 tabl.\n05909990609222 ¦ Rp ¦ EU/1/05/316/014 ¦ 33082\n112 tabl.\nRp ¦ EU/1/05/316/011 ¦ 107219\n84 tabl.\nRp ¦ EU/1/05/316/012 ¦ 107220\n98 tabl.\n05901878600406 ¦ Rp ¦ EU/1/05/316/010 ¦ Delfarma Sp. z o.o. ¦ 130108\n56 tabl.",
"substance": null,
"common_name": "Ivabradinum",
"pl_product_id": "100147065",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about ivabradine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.